Business Description
Haleon PLC
ISIN : GB00BMX86B70
Compare
Compare
Traded in other countries / regions
HLN.UKHLN.USAH6D0.GermanyHLN.Mexico IPO Date
2022-07-18Description
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.06 | |||||
| Equity-to-Asset | 0.5 | |||||
| Debt-to-Equity | 0.53 | |||||
| Debt-to-EBITDA | 3.99 | |||||
| Interest Coverage | 4.97 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 2.9 | |||||
| Beneish M-Score | -2.62 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 4.4 | |||||
| 3-Year EBITDA Growth Rate | 7.1 | |||||
| 3-Year EPS without NRI Growth Rate | 1.2 | |||||
| 3-Year FCF Growth Rate | 17.2 | |||||
| 3-Year Book Growth Rate | -14 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 6.85 | |||||
| Future 3-5Y Total Revenue Growth Rate | 2.23 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 50.05 | |||||
| 9-Day RSI | 55.86 | |||||
| 14-Day RSI | 55.91 | |||||
| 6-1 Month Momentum % | 13.86 | |||||
| 12-1 Month Momentum % | 18.29 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.84 | |||||
| Quick Ratio | 0.58 | |||||
| Cash Ratio | 0.09 | |||||
| Days Inventory | 119.16 | |||||
| Days Sales Outstanding | 59.89 | |||||
| Days Payable | 244.37 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.63 | |||||
| Dividend Payout Ratio | 0.47 | |||||
| Forward Dividend Yield % | 1.63 | |||||
| 5-Year Yield-on-Cost % | 1.63 | |||||
| Shareholder Yield % | 4.52 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 60.29 | |||||
| Operating Margin % | 18.92 | |||||
| Net Margin % | 10.75 | |||||
| FCF Margin % | 15.69 | |||||
| ROE % | 7.3 | |||||
| ROA % | 3.57 | |||||
| ROIC % | 4.87 | |||||
| ROC (Joel Greenblatt) % | 118.68 | |||||
| ROCE % | 7.72 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 28.83 | |||||
| Forward PE Ratio | 19.85 | |||||
| PE Ratio without NRI | 29.05 | |||||
| Price-to-Owner-Earnings | 22.55 | |||||
| PS Ratio | 3.12 | |||||
| PB Ratio | 2.09 | |||||
| Price-to-Free-Cash-Flow | 20.03 | |||||
| Price-to-Operating-Cash-Flow | 16.77 | |||||
| EV-to-EBIT | 19.29 | |||||
| EV-to-Forward-EBIT | 19.19 | |||||
| EV-to-EBITDA | 19.29 | |||||
| EV-to-Forward-EBITDA | 16.8 | |||||
| EV-to-Revenue | 3.82 | |||||
| EV-to-Forward-Revenue | 3.68 | |||||
| EV-to-FCF | 24.32 | |||||
| Earnings Yield (Greenblatt) % | 5.19 | |||||
| FCF Yield % | 5.13 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Haleon PLC Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil £) | 11,240 | ||
| EPS (TTM) (£) | 0.132 | ||
| Beta | 0 | ||
| Volatility % | 16.82 | ||
| 14-Day RSI | 55.91 | ||
| 14-Day ATR (£) | 0.056824 | ||
| 20-Day SMA (£) | 3.78335 | ||
| 12-1 Month Momentum % | 18.29 | ||
| 52-Week Range (£) | 3.0837 - 4.00649 | ||
| Shares Outstanding (Mil) | 9,042.96 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Haleon PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Haleon PLC Stock Events
| Event | Date | Price(£) | ||
|---|---|---|---|---|
| No Event Data | ||||
Haleon PLC Frequently Asked Questions
What is Haleon PLC(LSE:HLN)'s stock price today?
The current price of LSE:HLN is £3.81. The 52 week high of LSE:HLN is £4.01 and 52 week low is £3.08.
When is next earnings date of Haleon PLC(LSE:HLN)?
The next earnings date of Haleon PLC(LSE:HLN) is 2025-02-28 Est..
Does Haleon PLC(LSE:HLN) pay dividends? If so, how much?
The Dividend Yield %  of Haleon PLC(LSE:HLN) is 1.63% (As of Today), Highest Dividend Payout Ratio of Haleon PLC(LSE:HLN) was 0.47. The lowest was 0.24. And the median was 0.24. The  Forward Dividend Yield % of Haleon PLC(LSE:HLN) is 1.63%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers